Contribution of randomised controlled trials to understanding and management of early breast cancer

British Medical Journal

Volumn 319, Issue 7209, 1999, Pages 568-571

  Baum, Michael ^a   Houghton, Joan ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; HUMAN; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL PSYCHOLOGY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FORECASTING; HUMANS; LONG-TERM CARE; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033612847     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 1 Holmberg L, Baum M. Work on your theories! Nature Med 1996;2:844-6.
2. 2 Kuhn T. The structure of scientific revolutions. Chicago: Chicago University Press, 1970.
3. 3 Paterson R, Russell MH. Clinical trials in malignant disease. Part III. Breast cancer: evaluation of postoperative radiotherapy. J Faculty Radiol 1959;10:175-80.
4. 4 Fisher B, Montague E, Redmond C. Findings from NSABP protocol No B-04 - comparison of radical mastectomy with alternative treatments for primary breast cancer. 1: Radiation compliance and its relation to treatment outcome. Cancer 1980;46:1-13.
5. 5 Cancer Research Campaign Working Party. Cancer Research Campaign (King's/Cambridge) trial for early breast cancer. Lancet 1980;ii:55-60.
6. 6 Cuzick H, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-53.
7. 7 Overgaard M, Christensen JJ, Johansen H. Postmastectomy irradiation in high-risk breast cancer patients. Acta Oncol 1988;27:707-14.
8. 8 Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62.
9. 9 Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: a report after ten years of a clinical trial. BMJ 1972;ii:123-9.
10. 10 Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of randomised trials. N Engl J Med 1995;333:1444-55.
11. 11 Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. BMJ 1986;293:1331-4.
12. 12 Fallowfield LJ, Baum M. Psychosocial problems associated with the diagnosis and treatment of breast cancer. In: Bland KI, Copeland EM III, eds. The breast. Philadelphia: WB Saunders & Co, 1991:1081-92.
13. 13 Fisher B, Montague E, Redmond C. Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 1977;39:2827-39.
14. 14 Houghton J, Baum M, Haybittle JL, on behalf of the Closed Trials Working Party of the CRC Breast Cancer Trials Group. Role of radiotherapy following total mastectomy in patients with early breast cancer. World J Surg 1994;18:117-22.
15. 15 Haybittle JL, Brinkley D, Houghton J, A'Hern RP, Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 1989;298:1611-4.
16. 16 Beatson G. On the treatment of inoperable cases of carcinoma of the manoma: suggestions for a new method of treatment with illustrative cases. Lancet 1896;ii:104-7.
17. 17 Cole MP. A clinical tial of an artificial menopause in carcinoma of the breast. Inserm 1975;55:143-50.
18. 18 Nissen-Meyer R. The role of prophylactic castration in the therapy of human mammary cancer. Eur J Cancer 1967;3:395-403.
19. 19 Early Breast Cancer Trialists' Collaborative Group. A systematic overview of all available randomized trials of adjuvant endocrine and cytotoxic therapy. Oxford: Oxford University Press, 1990:1-207.
20. 20 Rutqvist LE, Zoladex and tamoxilen as adjuvant therapy in premenopausal breast cancer: a randomised trial by the Cancer Research Campaign (CRC) Breast Cancer Trials Group, the Stockholm Breast Cancer Study Group, the South-east Sweden Breast Cancer Group & Gruppo Interdisciplinate Valutazione Interventi in Oncologia (GIVIO) [abstract]. Proc ASCO 1999;18:67a.
21. 21 Harper PK, Walpole A. Contrasting endocrine activities of the cis and trans isomers in a series of triphenyl ethylenes. Nature 1966;212:87.
22. 22 Baum M, Brinkley DM, Dossett JA, McPherson K, Patterson JS, Rubens RD, et al. Improved survival amongst patients treated with adjuvant tamoxilen after mastectomy for early breast cancer. Lancet 1983;i:150.
23. 23 Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy, 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992;339:71-85.
24. 24 Swedish Breast Cancer Cooperative Group. Randomized trial for two versus five veafs of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 1996;88:1543-9.
25. 25 Current Trials Working Party Cancer Research Campaign Breast Cancer Trials Group. Preliminary results from the Cancer Research Campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. J Natl Cancer Inst 1996;88:1834-9.
26. 26 Cuzick J, Baum M. Tamoxifen and contralateral breast cancer. Lancet 1985;i:282.
27. 27 Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451-67.
28. 28 Nissen-Meyer R, Kjellgrett K, Malmio K, Mansson B, Norin T. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1978;41:2088-98.
29. 29 Baum M, Houghton J, Riley D. Results of the Cancer Research Campaign adjuvant trial for perioperative cyclophosphamide and long-term tamoxifen in early breast cancer reported at the tenth year of follow-up. Acta Oncol 1992;31:251-7.
30. 30 Fisher B, Carbone P, Economou SG. L-phenylalanine mustard (L-pam) in the management of primary breast cancer: a report of early findings. N Engl J Med 1975;292:117-22.
31. 31 Bonadonna G, Rossi A, Valagussa P. Adjuvant CMF chemotherapy in operable breast cancer: ten years later. Lancet 1985;i:976-7.
32. 32 Rubens RD, Bulbrook RD, Wang DY. The effect of adjuvant chemotherapy on endocrine function in patients with operable breast cancer. In: Salmon S, Jones S, eds. Adjuvant therapy of cancer. Amsterdam, Elsevier/North-Holland Biomedical Press, 1977:101-7.
33. 33 Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 1998;352:930-42.
34. 34 Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia-Giralt E, et al. Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer 1991;27:1668-71.
35. 35 Bonadonna G, Valagussa P, Brambilla C, Moliterni A, Zambetti M, Ferrari L. Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. Semin Oncol 1991;18:515-24.
36. 36 Mamounas EP. Overview of national surgical adjuvant breast project neoadjuvant chemotherapy studies. Semin Oncol 1998;25:31-5.
37. 37 Beral V, Hermon C, Reeves G. Sudden fall in breast cancer death rates in England and Wales. Lancet 1995;345:1642-3.